WallStreetZenWallStreetZen

NASDAQ: CLSD
Clearside Biomedical Inc Stock Forecast, Predictions & Price Target

Analyst price target for CLSD

Based on 4 analysts offering 12 month price targets for Clearside Biomedical Inc.
Min Forecast
$4.00+139.52%
Avg Forecast
$4.75+184.43%
Max Forecast
$6.00+259.28%

Should I buy or sell CLSD stock?

Based on 4 analysts offering ratings for Clearside Biomedical Inc.
Buy
Strong Buy
0 analysts 0%
Buy
4 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLSD stock forecasts and price targets.

CLSD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-03-13

1 of 1

Forecast return on equity

Is CLSD forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is CLSD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CLSD revenue forecast

What is CLSD's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$3.9M-53.12%
Avg 2 year Forecast
$14.7M+78.88%
Avg 3 year Forecast
$34.2M+315.69%
CLSD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLSD revenue growth forecast

How is CLSD forecast to perform vs Biotechnology companies and vs the US market?
Company
58.37%
Industry
38.94%
Market
10.52%
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLSD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLSD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLSD$1.67$4.75+184.43%Buy
KNTE$2.66$2.30-13.72%Hold
SEER$1.94N/AN/A
VTGN$4.57$13.50+195.40%Strong Buy
ANVS$12.03$25.00+107.81%Buy

Clearside Biomedical Stock Forecast FAQ

Is Clearside Biomedical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CLSD) stock is to Buy CLSD stock.

Out of 4 analysts, 0 (0%) are recommending CLSD as a Strong Buy, 4 (100%) are recommending CLSD as a Buy, 0 (0%) are recommending CLSD as a Hold, 0 (0%) are recommending CLSD as a Sell, and 0 (0%) are recommending CLSD as a Strong Sell.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.

What is CLSD's revenue growth forecast for 2024-2026?

(NASDAQ: CLSD) Clearside Biomedical's forecast annual revenue growth rate of 58.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Clearside Biomedical's revenue in 2024 is $8,226,000.On average, 3 Wall Street analysts forecast CLSD's revenue for 2024 to be $288,124,712, with the lowest CLSD revenue forecast at $44,832,683, and the highest CLSD revenue forecast at $718,070,146. On average, 2 Wall Street analysts forecast CLSD's revenue for 2025 to be $1,099,521,560, with the lowest CLSD revenue forecast at $993,043,937, and the highest CLSD revenue forecast at $1,205,999,183.

In 2026, CLSD is forecast to generate $2,555,089,348 in revenue, with the lowest revenue forecast at $2,439,645,188 and the highest revenue forecast at $2,670,533,508.

What is CLSD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CLSD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CLSD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CLSD price target, the average CLSD price target is $4.75, with the highest CLSD stock price forecast at $6.00 and the lowest CLSD stock price forecast at $4.00.

On average, Wall Street analysts predict that Clearside Biomedical's share price could reach $4.75 by Mar 14, 2025. The average Clearside Biomedical stock price prediction forecasts a potential upside of 184.43% from the current CLSD share price of $1.67.

What is CLSD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CLSD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.